✦ LIBER ✦

Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease

✍ Scribed by Jagdip S Sidhu; Dahlia Cowan; Jennifer A Tooze; Juan-Carlos Kaski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peroxisome proliferator–activated recept

✍ Guang Wang; Jinru Wei; Youfei Guan; Nan Jin; Jieming Mao; Xian Wang 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Peroxisome proliferator–activated recept

✍ Jie Yu; Nan Jin; Guang Wang; Fuchun Zhang; Jieming Mao; Xian Wang 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 215 KB

W01.103 Peroxisome proliferator-activate

✍ Chao, T.; Tsai, W.; Li, Y.; Chen, J.; Wu, H.; Liu, P. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 152 KB

The expression receptor of peroxisome pr

✍ Izabela Wojtkowska; Andrzej Tysarowski; Katarzyna Seliga; Janusz A. Siedlecki; Z 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 271 KB

The effects of rosiglitazone, a peroxiso

✍ J.S. Sidhu; D. Cowan; J.C. Kaski 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 35 KB

The effects of rosiglitazone, a peroxiso

✍ Jagdip S Sidhu; Dahlia Cowan; Juan-Carlos Kaski 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 134 KB